文摘
The synthesis of different 4-arylcoumarin analogues of combretastatin A-4 led to theidentification of two new compounds (1 and 2) with potent cytotoxic activity on a CEM leukemia cellline and a third one completely inactive (compound 3). It was suggested that the cytotoxicity of compounds1 and 2 may be related to their interaction with microtubules and tubulin, since these compounds inhibitmicrotubule formation from purified tubulin in vitro [Bailly et al. (2003) J. Med. Chem. 46 (25), 5437-5444]. In the present study, tubulin was identified as the main target of these molecules. We studiedstructure-activity relationships of these compounds using biological experiments specific for tubulinbinding. The modification of cell cycle progression induced by compounds 1 and 2 was characterized byan apoptotic induction on human breast cells (HBL100). In addition, these two molecules disturbed cellsurvival by depolymerizing the microtubule network, leading to a mitotic block. We then determined thethermodynamic parameters of their interaction with purified tubulin by fluorescence spectroscopy andisothermal microcalorimetry. These results, together with a superimposition of the molecule on colchicinein the X-ray-determined three-dimensional structure model of tubulin-colchicine complex, allowed us toidentify the pharmacophore of the combretastatin A-4 analogues responsible for their biological activity.